# AZD6140 Oral Contraceptive Interaction Study

> **NCT00685906** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD6140
- **DRUG:** Levonorgestrel and Ethinyl Estradiol (Nordette®)

## Key facts

- **NCT ID:** NCT00685906
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685906, "AZD6140 Oral Contraceptive Interaction Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00685906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*